n. an antimetabolite that interferes with pyrimidine synthesis and is used to suppress the symptoms of acute myeloblastic leukaemia. It is administered by subcutaneous, intravenous, or intrathecal injection and can damage the normal bone marrow, leading to various blood cell disorders. Other side-effects are nausea, vomiting, mouth ulcers, and diarrhoea. Trade name: DepoCyte.
Subjects: Medicine and Health — Chemistry.